Opinion|Videos|February 17, 2025

Advancing to Systemic Treatment in an 8-Year-Old Girl With Atopic Dermatitis

The panelist discusses how an 8-year-old girl with moderate to severe atopic dermatitis requires a comprehensive treatment approach focusing on dupilumab as a potential systemic therapy. Treatment goals include reducing inflammation, improving quality of life, and providing age-appropriate, empathetic care while addressing patient and caregiver concerns about efficacy and safety.

Video content above is provided by the following:

  • Please share your impressions of the case. What aspects of the case are most relevant for treatment consideration?
  • What are your treatment goals for this patient?
  • Describe your approach to pharmacologic treatment for this patient. Would her history and presentation make her a candidate for systemic therapy?
  • How do you approach the conversation with pediatric patients and their caregivers when initiating a systemic, injectable treatment for atopic dermatitis?
  • What should this patient expect in terms of efficacy and safety with dupilumab? How soon can she expect initial symptom relief?
  • How would you address potential patient/caregiver concerns such as fear of injections or adverse effects and long-term safety with dupilumab?

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME